The lactoferrin market is experiencing robust growth as consumer awareness of its immune-supporting and nutritional benefits increases. Lactoferrin—a multifunctional protein found in milk and produced via precision fermentation—is increasingly used in infant formulas, dietary supplements, functional foods, pharmaceuticals, and skincare. Innovation in production technologies, including precision fermentation and advanced purification methods, is enhancing scalability and reducing costs. The market is led by Asia‑Pacific (with over 50% share), while Western regions see slower uptake due to limited regulatory approval and consumer awareness. As interest in clean-label functional ingredients rises, lactoferrin is poised to become a key ingredient in health and wellness formulations.
According to Fortune Business Insights, the global lactoferrin market was valued at USD 610.9 million in 2024. The market is projected to grow from USD 615.9 million in 2025 to USD 1,005.5 million by 2032, exhibiting a CAGR of 7.3% during the forecast period. In 2024, Asia Pacific dominated the lactoferrin market with a market share of 56.02%.
FrieslandCampina Ingredients secured the U.S. GRAS (Generally Recognized as Safe) status for its “Vivinal lactoferrin,” marking a major milestone. This regulatory acknowledgment clears the path for its use in infant and toddler nutrition products—unlocking fresh avenues in a high-growth segment .